Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin... (third Phase 2a study to evaluate the abi...)

Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program

Date:8/19/2007

third Phase 2a study to evaluate the ability of MEDI-528 to inhibit the biological activity of IL-9 in the bronchoalveolar lavage fluid of adult patients with atopic asthma are underway.

About IL-9

As mentioned above, IL-9 has been associated with symptoms of asthma. It is one of at least 29 naturally occurring interleukins in the human body. Overexpression of IL-9 in animal models has been shown to result in many features of asthma, including increased airway inflammation and hyperreactivity. Blocking the actions of IL-9 has been shown to reduce the airway inflammation and increased airway inflammation and increased airway hyperresponsiveness seen in animal models of asthma. MedImmune is conducting research to evaluate the potential to use MAbs targeting IL-9 to treat or prevent symptomatic, moderate-to-severe, persistent asthma.

About Asthma

Asthma is a chronic disease of the airways that may cause wheezing, breathlessness, chest tightness and coughing. According to the U.S. Centers for Disease Control and Prevention (CDC), more than 30 million Americans reported having a history of asthma in 2003. About 20 million said they currently had asthma. In 2000, the CDC reported that there were more than 10 million asthma-related outpatient visits to private physician offices and hospital clinics. The National Institutes of Health (NIH) have estimated asthma-related healthcare costs in the U.S. at $14 billion annually.

About Genaera

Genaera Corporation is focused on advancing the science and treatment of metabolic diseases. The Company has significant market opportunities with a first-in-class molecule, trodusquemine (MSI-1436), that has the potential to redefine the treatment paradigm for obesity and type 2 diabetes and is presently in a Phase 1 trial in obesity. In addition, Genaera has a value-driven, fully out-licensed partnership with MedImmune, Inc. for a second core program that is presently undergoing Phase 2 clinical testing i
'/>"/>

SOURCE Genaera Corporation

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

Post Your Comments:

(Date:6/19/2013)... YORK , June 19, 2013 /PRNewswire-iReach/ -- ... pioneer of modern hair transplant procedures and founder ... was included in the ,Best Doctors, issue of ... (Photo: http://photos.prnewswire.com/prnh/20130619/CG34629 ) ... Best Doctors issue, and his reputation as world-renowned ...

(Date:6/19/2013)... The American Association for Homecare (AAHomecare), along with ... , announced today the filing of a lawsuit ... , asking that the scheduled July 1 expansion of the ... be stopped because of serious licensing irregularities. The ... (HHS) Secretary Kathleen Sebelius as the defendant. HHS ...

(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ ... a new market research report is ... Partnerships, Licensing, Investments and M&A ... in Pharmaceuticals http://www.reportlinker.com/p0925641/Partnerships-Licensing-Investments-and-MA-Deals-and-Trends-for-May-2013-in-Pharmaceuticals.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Investment_Banking ... and M&A Deals and Trends for ...

[0] Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year [0] AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program [0] Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals

... New Data to be Presented at ASCO Shows Survival ... Partial Responders Compared with Chemotherapy ... (OTC Bulletin Board: GNTA) announced the results of long-term,followup ... oncology product,Genasense(R) (oblimersen sodium) Injection, in patients with chronic,lymphocytic ...

... Wyeth,Pharmaceuticals, a division of Wyeth (NYSE: WYE ... Administration (FDA) has granted Fast Track designation,to the ... toddlers. Wyeth is seeking a pediatric indication for,active ... caused by serotypes included in the vaccine. The ...

Cached Medicine Technology:Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 2 Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 3 Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 4 Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers 2 Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers 3 Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers 4

Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers

(Date:6/19/2013)... 2013 Brand new Hypertrophy Max bonus just released ... sale on the Hypertrophy Max program. Vince and Ben are ... those that are interested must act quickly. , What is the ... bonus is a free 12 month all access pass to the ... Ryan Davids "Live Large TV is a Monday night show where ...

(Date:6/19/2013)... Neb. (PRWEB) June 20, 2013 Author Byron ... give children a basic explanation of how the body’s defense ... Brownie Bill and the Health Pirates ” (published by Trafford ... and the Health Pirates” tells the story of Bobbie, a ... fever one morning. His mother takes him to visit Doctor ...

(Date:6/19/2013)... Colorado (PRWEB) June 19, 2013 Daily Gossip ... vertical jump training method will be published on their ... preview of the article to inform readers about the information ... declaration made by reporters working at Daily Gossip, the article ... Guide . , Hiller has understood during the vast ...

(Date:6/19/2013)... (PRWEB) June 19, 2013 PrettySkin4Less announces ... organic skin serums by top skin care manufacturer ... high concentrations of vitamins, minerals and active organic ingredients ... that so many other beauty products offer. For this ... lining up. , "I like products that do ...

(Date:6/19/2013)... UT (PRWEB) June 19, 2013 ... , In July 2013, Orriant is launching a ... rates, and maintain compliance with regulations. New ... to receive wellness incentives if their employer offers ... they have been compliant with these standards for ...

Breaking Medicine News(10 mins):Health News:New Hypertrophy Max Bonus Just Released and Only Available for 24 Hours 2 Health News:New Book Shows Children How the Body Fights Germs 2 Health News:The Jump Manual Review: Reveals Hiller’s Method of Vertical Jump Training 2 Health News:PrettySkin4Less Launches New Innovative Skin Serums with Active Organic Ingredients to World Wide Consumer Base 2 Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 2 Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 3

[0] New Hypertrophy Max Bonus Just Released and Only Available for 24 Hours [0] New Book Shows Children How the Body Fights Germs [0] The Jump Manual Review: Reveals Hiller’s Method of Vertical Jump Training [0] PrettySkin4Less Launches New Innovative Skin Serums with Active Organic Ingredients to World Wide Consumer Base [0] New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations

... common type of disorder in which the patient develops tingling and ... approved the drug to be sold to treat the disorder. It ... about 10% of the people are affected by this disorder. ... of now it is used to treat mild to moderate or ...

... here lawyers in California have sued PepsiCo alleging one of ... drink in question is Pepsi Twist drink, and it is ... firms has been drawn into a legal battle. ,Lawyers ... Twist has been falsely promoted as a safe consumer product, ...

... the anti-quota camp, the Supreme Court Friday reversed an ... seats on an all-India basis// for scheduled castes and ... 2006-07 academic year. ,A bench of judges K.G. ... of Additional Solicitor General Gopal Subramaniam that enforcing the ...

... of Orissa, declared that his health is normal. // The ... after he ran an astounding 65km earlier this week. ... Bhubaneswar for a medical check up on the orders of ... Biranchi Das was exploiting the boy for his personal gains. ...

... India (MCI) has condemned the poor infrastructure, lack lustre teaching ... // ,The (MCI) delegation, headed by Dr Lalita ... college and its failure to set up proper infrastructure over ... the college building was another factor of contention and a ...

... Lomb Inc. is in serious trouble after an eye infection ... its lens care products.// There are complaints arising from Asia, ... lens care products might be linked to a spate of ... a handful of cases of the infection had also been ...

Cached Medicine News:Health News:Supreme Court Quashed Reservation Quotas For PG Medical Courses 2 Health News:Marathon Kid Budhia’s Health Not Compromise 2

Mirapexin to Treat Restless Leg Syndrome Pepsi company in a lawsuit(soup)!Supreme Court Quashed Reservation Quotas For PG Medical Courses Marathon Kid Budhia’s Health Not Compromise Agartala Medical College under Fire from MCI Contact Lens Care Products Results In Eye Infection

Medpor 2/3 Orbit implants are designed to replace non load bearing bony structures in the orbital area....

... Orbital Rim implant can provide up to ... to be trimmed to meet the needs ... allows it to rest on the most ... flange allows easier positioning of the implant ...

Flattened points in vertical plane, straight shafts, cross action, round handle....

1.5 mm inner cutting edge....

Medicine Products:

MEDPOR 2/3 Orbit Complex MEDPOR Inferior Orbital Rims Akahoshi Prechop (12 o'clock approach)Appasamy Phaco Choppper